These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 930178)

  • 1. [Porphyria cutanea tarda after uptake of lead--a case contribution to the etiology].
    Zschunke E; Wolf I
    Z Gesamte Inn Med; 1977 Jun; 32(11):248-50. PubMed ID: 930178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Case of porphyria cutanea tarda in a patient with occupational exposure to lead and tetraethyl-lead petrol].
    Bielawska-Krasnowiecka G; Jaremin B
    Wiad Lek; 1979 Feb; 32(3):199-202. PubMed ID: 442650
    [No Abstract]   [Full Text] [Related]  

  • 3. [The effect of exposure to silicon oxides on the occurrence of porphyria cutanea tarda].
    Hykes P; Kordac V; Havránková E
    Sb Lek; 1989 Sep; 91(8):249-52. PubMed ID: 2559473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acne chlorina and porphyria cutanea tarda during the manufacturing of herbicides].
    Jirásek L; Kalenský J; Kubec K
    Cesk Dermatol; 1973 Oct; 48(5):306-17. PubMed ID: 4271621
    [No Abstract]   [Full Text] [Related]  

  • 5. [Porphyria cutanea tarda and chloracne in the manufacture of cyclic chlorinated hydrocarbons].
    Gombos B; Pechánová A; Koziak B; Moscovicová E
    Bratisl Lek Listy; 1969; 51(5):640-5. PubMed ID: 4240000
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effect of exposure to silicon dioxide on the occurrence of porphyria tarda].
    Hykes P; Kordac V; Havránková E
    Sb Lek; 1989 Sep; 91(8-9):249-52. PubMed ID: 2562772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic cirrhosis and porphyria cutanea tarda in a subject occupationally exposed to methyl chloride].
    Leurini D; Giannini M; Riboldi L; Alessio L
    Med Lav; 1982; 73(6):571-4. PubMed ID: 7167097
    [No Abstract]   [Full Text] [Related]  

  • 8. [Gas station attendant with chronic recurrent abdominal pain. Unusual lead exposure lead to secondary porphyria].
    Fischer HJ; Herrmann M; Jacob K; Borck V
    MMW Fortschr Med; 2001 May; 143(21):46-8. PubMed ID: 11420832
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chloracne, porphyria cutanea tarda, and other poisonings due to the herbicides].
    Jirásek L; Kalenský J; Kubec K; Pazderová J; Lukás E
    Hautarzt; 1976 Jul; 27(7):328-33. PubMed ID: 134006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Porphyria cutanea tarda caused by long-term use of femigen].
    Chowaniec O; Wierzbieta J
    Przegl Dermatol; 1980; 67(3):349-52. PubMed ID: 6159665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Porphyria cutanea tarda and sarcoma in a worker exposed to 2, 3, 7, 8-tetrachlorodibenzodioxin--Missouri.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1984 Mar; 33(8):113-4. PubMed ID: 6422252
    [No Abstract]   [Full Text] [Related]  

  • 12. Leads from the MMWR. Porphyria cutanea tarda and sarcoma in a worker exposed to 2,3,7,8-tetrachlorodibenzodioxin-Missouri.
    JAMA; 1984 Mar 23-30; 251(12):1534, 1537. PubMed ID: 6538243
    [No Abstract]   [Full Text] [Related]  

  • 13. [Development of porphyria cutanea tarda after oral contraceptive therapy. Case report].
    Vosmík F; Kordac V
    Cesk Dermatol; 1974 Oct; 49(5):298-303. PubMed ID: 4429985
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coexistence of porphyria cutanea tarda and lupus erythematosus].
    Morvay M; Hunyadi J; Kószó F; Kiss M; Dobozy A; Simon N
    Dermatol Monatsschr; 1989; 175(1):20-7. PubMed ID: 2920861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further discussion concerning porphyria cutanea tarda and TCDD exposure.
    Jones RE; Chelsky M
    Arch Environ Health; 1986; 41(2):100-3. PubMed ID: 3521500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porphyria cutanea tarda and the pill: case report.
    Austad WI; Hamilton-Gibbs JS
    N Z Med J; 1975 Jan; 81(531):8-10. PubMed ID: 1055316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Extrasystemic factors in the pathogenesis and prevention of porphyria cutanea tarda].
    Kaszewska I; Bielawski W; Piskozub E; Stankiewicz J
    Przegl Dermatol; 1986; 73(6):457-63. PubMed ID: 3035623
    [No Abstract]   [Full Text] [Related]  

  • 18. Porphyria cutanea tarda induced by natural estrogens. A case report.
    Stein KM; Raque CJ; Zeigerman JH; Shrager JD
    Obstet Gynecol; 1971 Nov; 38(5):755-60. PubMed ID: 5114226
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possible side effect of hormonal contraception: porphyria cutanea tarda].
    Zaumseil RP; Fiedler H
    Zentralbl Gynakol; 1983; 105(8):527-31. PubMed ID: 6868877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An inherited enzymatic defect in porphyria cutanea tarda: decreased uroporphyrinogen decarboxylase activity.
    Kushner JP; Barbuto AJ; Lee GR
    J Clin Invest; 1976 Nov; 58(5):1089-97. PubMed ID: 993332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.